G/TBT/N/KOR/1112  
2 November 2022  
(22-8221) Page: 1/2 
Committee on Technical Barriers to Trade  Original:  English  
 
  
NOTIFICATION  
The following notification is being circulated in accordance with Article 10.6  
 
1. Notifying Member:  REPUBLIC OF KOREA  
If applicable, name of local government involved (Article 3.2 and 7.2):   
2. Agency responsible:   
Ministry of Food and Drug Safety  
Name and address (including telephone and fax numbers , email and website 
addresses, if available) of agency or authority designated to handle comments 
regarding the notification shall be indicated if different from above:   
Documents are available from the Ministry of Food and Drug safety (MFDS) website : 
www.mfds.go.kr  
International Cooperation Office  
Ministry of Food and Drug Safety  
187 Osongsaengmyeong2 -ro, Osong -eup, Heungdoek -gu Cheongju -si, Chungcheongbuk -
do, 28159  
Republic of Korea  
Tel: (+82) 43 719 -1564 
Fax: (+82) 43 -719-1550 
Email: intmfds@korea.kr  
3. Notified under Article 2.9.2 [X], 2.10.1 [  ], 5.6.2 [  ], 5.7.1 [  ], 3.2 [  ], 7.2 [  ], 
other :  
4. Products covered (HS or CCCN where applicable, otherwise national tariff 
heading. ICS numbers may be provided in addition, where applicable):  
Pharmaceuticals  
5. Title, number of pages and language(s) of the notified document:  Proposed 
amendments to the "Korean Pharmacopoeia"; (88 page(s), in Korean)  
6. Description of content:  The revision aims to provide reasonable support for proper 
pharmaceutical quality management by harmonizing standards and specifications in The 
Korean Pharmacopoeia with global standards a nd specifications. Moreover, the revision 
includes adding to the licorice origin species a species which the standard conformity with 
the existing species and the possibility of domestic cultivation were verified to lay the 
foundation for the localization of licorice.  
In addition, to advance standards and specifications and distribute high -quality medicines 
by improving some of the general information that incorporated the development of 
advanced biopharmaceuticals and the demands of the pharmaceutical indu stry in line with 
the latest scientific level.  
A. Addition of verified species to the origin of Licorice and incorporation of properties to 
the added species (Annex 4 of the draft)  G/TBT/N/KOR/1112  
 
- 2 - 
 
  B. Addition of flow cytometry, enzyme -linked immunosorbent assay (ELISA), a nd 
immunoblot analysis to general information (Annex 6 of the draft)  
7. Objective and rationale, including the nature of urgent problems where 
applicable:  Other  
8. Relevant documents:  MFDS NOTIFICATION No. 2022 -488 (1 November 2022)  
9. Proposed date of adoption:  To be determined  
Proposed date of entry into force:  To be determined  
10. Final date for comments:  60 days from notification  
11. Texts available from:  National enquiry point [ ] or address, telephone and fax 
numbers and email and website addresses, if available , of other body:   
Technical Barriers to Trade(TBT) Division  
Korean Agency for Technology and Standards (KATS)  
93, Isu -ro, Maengdong -myeon, Eumseong -gun, Chungcheongbuk -do, R epublic of Korea, 
369-811 
Tel.: (+82) 43 870 5521 Fax: (+82) 43 870 5682  
E-mail: tbt@korea.kr  Website: http://www.knowtbt.kr  
https://members.wto.org/crnattachments/2022/TBT/KOR/22_7401_00_x.pdf